Drug details
Vtama (tapinarof cream)
type of AHR Agonists
Vtama (tapinarof) cream, 1% is an aryl hydrocarbon receptor agonist indicated for the topical treatment of plaque psoriasis in adults.
This drug may have the following side effects:
- dizziness
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- inflammation of hair follicles at the application site, and
- itchy rash
The following drugs are related to Vtama, either as a replacement or used together:
- Humira (adalimumab injection solution for subcutaneous administration)
- Cyltezo (adalimumab-adbm injection, for subcutaneous use)
- Otezla (apremilast tablets)
- Siliq (brodalumab injection for subcutaneous use)
- Cosentyx (secukinumab injection)
- Enbrel (etanercept)
- Erelzi (etanercept-szzs injection)
- Tremfya (guselkumab for injection)
- Remicade (infliximab)
- Taltz (ixekizumab injection, for subcutaneous use)
- Skyrizi (risankizumab-rzaa injection)
- Stelara Injection (ustekinumab)